Additionally, mutations leading to APOB inactivation are correlated with the overexpression of oncogenic regulators and the downregulation of tumor suppressors, resulting in poorer survival outcomes in hepatocellular carcinoma (35). This evidence concerns the gene APOB and hepatocellular carcinoma.